Heart Failure Clinical Trials in Chengdu, Sichuan
6 recruitingChengdu, Sichuan, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled564 locationsNCT07037459
Recruiting
Phase 2
Study of JK07 in Patients With Chronic Heart Failure
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction
Salubris Biotherapeutics Inc282 enrolled62 locationsNCT06369298
Recruiting
Phase 4
SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
Heart Failure
China-Japan Friendship Hospital336 enrolled26 locationsNCT05583773
Recruiting
Not Applicable
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
Heart FailureNon-ischemic CardiomyopathyLeft Bundle-Branch Block
The First Affiliated Hospital with Nanjing Medical University50 enrolled6 locationsNCT05572957
Recruiting
Not Applicable
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
Heart FailureAtrioventricular Block, Second and Third DegreeSick Sinus Syndrome
The Third People's Hospital of Chengdu688 enrolled2 locationsNCT06652750
Recruiting
Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis
Heart FailureLiver CirrhosisTransjugular Intrahepatic Portosystemic Shunt (TIPS)
West China Hospital200 enrolled1 locationNCT05596253